A phase II/III, randomized, double-blind, placebo-controlled trial to evaluate immunogenicity and safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic treatment for SARS-СoV-2 infection in the United Arab Emirates

Related articles

1. Immunogenicity and Safety of Serum-Free Rabies Vaccine (Vero Cell) for Human Use, Freeze-Dried with Different Immunization Schedules: A Randomized, Double-Blind, Active-Controlled Phase Ⅰ/Ⅲ Clinical Trial

   This article has 9 authors:

   1. Yulin Jing
   2. Xiaoqiang Chang
   3. Zhongqiang Jin
   4. Fei Yang
   5. Yanbei Cai
   6. Kun Chen
   7. Shuo Liu
   8. Lin Huang
   9. Jing Li

2. The Safety and Efficacy of the Chikungunya Virus Vaccine: A Systematic Review and Meta Analysis.

   This article has 9 authors:

   1. Eman Ayman Nada
   2. Aya M. Fayod
   3. Abdelrahman Shata
   4. Nereen A. Almosilhy
   5. Amany Mahmoud Genidy
   6. Yasein Fadel Awadalla
   7. Sama M. Mahmoud
   8. Asmaa Zakria Alnajjar
   9. Muataz Kashbour

3. A Randomized, Double-Blind, Controlled, Parallel Group Study with Amustaline/Glutathione Pathogen Reduced Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS Study): -- Protocol for a Phase 3, Randomized, Controlled Trial

   This article has 24 authors:

   1. Edgardo F. Cartagena Ayala
   2. Lumen Vera Colon
   3. Yesim Aydinok
   4. Bolívar Arboleda-Osorio
   5. Arthur Bracey
   6. Ross Fasano
   7. Marianne Yee
   8. Ravindra Sarode
   9. Abba C. Zubair
   10. Frank Nizzi
   11. Sanjay Shah
   12. Edward L. Snyder
   13. Angela Treml
   14. Yan Zheng
   15. Clifford Takemoto
   16. Jeffrey Green
   17. Bryon Jackson
   18. John P Pitman
   19. Thomas J. Gniadek
   20. Kathy Liu
   21. Stanley Bentow
   22. Laurence Corash
   23. Nina Mufti
   24. Richard J. Benjamin